))
Newly Diagnosed Psoriasis Patients: Uncovering Racial Disparities in Primary Therapy
Manage episode 431487875 series 3589616
Contenu fourni par ReachMD. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par ReachMD ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Guest: Shari Lipner, MD
A recent study was conducted looking at initial therapies for newly diagnosed psoriasis patients by race. Prior studies have shown differences by race in terms of emerging treatments for different dermatological diseases, which have also shown differential biologic treatments based on race. To learn about the findings and how we can help fill this gap, join Dr. Shari Lipner, Associate Professor of Clinical Dermatology at Weill Cornell Medicine and co-author of the article, titled Racial Disparities in Primary Therapy for Newly Diagnosed Psoriasis Patients, which was published in the Journal of Drugs in Dermatology in July 2023.
…
continue reading
A recent study was conducted looking at initial therapies for newly diagnosed psoriasis patients by race. Prior studies have shown differences by race in terms of emerging treatments for different dermatological diseases, which have also shown differential biologic treatments based on race. To learn about the findings and how we can help fill this gap, join Dr. Shari Lipner, Associate Professor of Clinical Dermatology at Weill Cornell Medicine and co-author of the article, titled Racial Disparities in Primary Therapy for Newly Diagnosed Psoriasis Patients, which was published in the Journal of Drugs in Dermatology in July 2023.
8 episodes
Partager
